Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05998785 · ClinicalTrials.gov registry record
Embody Insertional Achilles Tendinopathy
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 8
- Enrollment target
NCT05998785: Clinical Trial study, sponsored by Zimmer Biomet.
NCT05998785 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05998785 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the long-term effects on ankle/Achilles tendon pain after repair of insertional Achilles tendinopathy (IAT) augmented with TAPESTRY Biointegrative Implant.
Primary Outcome
Visual Analog Scale (VAS) survey
Interventions
- DEVICE TAPESTRY Biointegrative Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-08-02 |
| Est. Completion | 2024-08-01 |
Why NCT05998785 stopped before completion
NCT05998785 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which TAPESTRY Biointegrative Implant is the first listed.
NCT05998785 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05998785 about?
NCT05998785 is a clinical study titled "Embody Insertional Achilles Tendinopathy". The primary objective of this study is to evaluate the long-term effects on ankle/Achilles tendon pain after repair of insertional Achilles tendinopathy (IAT) augmented with TAPESTRY Biointegrative Implant.
What is the current status of trial NCT05998785?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2022-08-02. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT05998785?
The interventions under investigation include: TAPESTRY Biointegrative Implant (DEVICE).
Who is sponsoring clinical trial NCT05998785?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI